Literature DB >> 25747764

Capillary microsampling of whole blood for mouse PK studies: an easy route to serial blood sampling.

Walter Korfmacher1, Maria Fitzgerald, Yongyi Luo, Stacy Ho, Jie Wang, Zhongtao Wu, Gregory Snow, Thomas O'Shea.   

Abstract

BACKGROUND: Capillary microsampling (CMS) of 8 µl of blood provides a methodology that can be utilized for serial sampling in drug discovery mouse PK studies.
RESULTS: Blood CMS sample results were compared to plasma sample results for three compounds (with expected Cb/Cp of 1 to 2) and found to be similar. In addition, for three compounds, blood CMS results were found to be equivalent to results generated with standard whole blood sampling. In a 5-day repeated dose PK study, four mice were dosed (IV) daily and sampled on both day one and day five using blood CMS procedure.
CONCLUSION: Blood CMS using 8 µl glass capillary microsamples provides a straightforward and effective approach for mouse serial blood sampling.

Entities:  

Mesh:

Year:  2015        PMID: 25747764     DOI: 10.4155/bio.14.275

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  3 in total

1.  Investigation on the Effect of Capillary Microsampling on Hematologic and Toxicokinetic Evaluation in Regulatory Safety Studies in Mice.

Authors:  Bonnie Wang; Linna Wang; Alicja Batog; Thomas Brodie; Lila Ramaiah; Kristina D Chadwick; Ting Su; Raja Mangipudy; Renuka C Pilutla; Qin C Ji
Journal:  AAPS J       Date:  2020-03-09       Impact factor: 4.009

2.  Fit-for-Purpose Validation of a Ligand Binding Assay for Toxicokinetic Study Using Mouse Serial Sampling.

Authors:  Liang Zhu; Ying Wang; Alison Joyce; Ihor Djura; Boris Gorovits
Journal:  Pharm Res       Date:  2019-10-25       Impact factor: 4.200

3.  A fast and cost-effective microsampling protocol incorporating reduced animal usage for time-series transcriptomics in rodent malaria parasites.

Authors:  Abhinay Ramaprasad; Amit Kumar Subudhi; Richard Culleton; Arnab Pain
Journal:  Malar J       Date:  2019-01-25       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.